簡介

本頁面提供了有關 Daniel J Levangie 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Daniel J Levangie已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:EXAS / Exact Sciences Corporation Director 34,312
US:PODD / Insulet Corporation EVP & President, Drug Delivery 21,122
US:LPDX / Liposcience Inc Director 0
US:HOLX / Hologic, Inc. Director 47,249
如何解讀這些圖表

以下圖表顯示了在Daniel J Levangie進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Daniel J Levangie 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2025-06-16 2025-06-12 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 5,398 34,312 18.67
2024-12-20 2024-06-13 4/A EXAS EXACT SCIENCES CORP
Common Stock
A - Award 5,939 28,914 25.85
2024-06-17 2024-06-13 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 5,444 28,419 23.70
2024-03-04 2024-03-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -5,000 22,975 -17.87 57.50 -287,500 1,321,062
2023-06-12 2023-06-08 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 4,678 27,975 20.08
2022-06-13 2022-06-09 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 5,606 23,297 31.69
2021-07-02 2021-06-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 2,675 17,691 17.81
2020-08-04 2020-07-31 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -5,257 0 -100.00
2020-08-04 2020-07-31 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -4,608 0 -100.00
2020-08-04 2020-07-31 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -9,865 15,016 -39.65 94.00 -927,310 1,411,504
2020-08-04 2020-07-31 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 5,257 24,881 26.79 8.52 44,790 211,986
2020-08-04 2020-07-31 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 4,608 19,624 30.69 10.18 46,909 199,772
2020-07-24 2020-07-23 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 2,558 15,016 20.53
2019-08-02 2019-07-31 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -15,772 0 -100.00
2019-08-02 2019-07-31 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -7,667 0 -100.00
2019-08-02 2019-07-31 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise -19,168 0 -100.00
2019-08-02 2019-07-31 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -100 12,458 -0.80 120.24 -12,024 1,497,950
2019-08-02 2019-07-31 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -8,897 12,558 -41.47 119.63 -1,064,348 1,502,314
2019-08-02 2019-07-31 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -9,626 21,455 -30.97 118.73 -1,142,895 2,547,352
2019-08-02 2019-07-31 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -9,572 31,081 -23.55 117.72 -1,126,816 3,658,855
2019-08-02 2019-07-31 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -2,300 40,653 -5.35 116.47 -267,881 4,734,855
2019-08-02 2019-07-31 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -9,284 42,953 -17.77 115.65 -1,073,695 4,967,514
2019-08-02 2019-07-31 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X -2,828 52,237 -5.14 114.83 -324,739 5,998,375
2019-08-02 2019-07-31 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 15,772 55,065 40.14 8.52 134,377 469,154
2019-08-02 2019-07-31 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 7,667 39,293 24.24 3.43 26,298 134,775
2019-08-02 2019-07-31 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 19,168 31,626 153.86 3.43 65,746 108,477
2019-07-26 2019-07-25 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 2,784 12,458 28.78
2019-02-08 2018-05-01 5 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift -68,324 9,674 -87.60
2018-07-30 2018-07-26 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 4,401 77,998 5.98
2017-07-31 2017-07-27 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 7,119 73,597 10.71
2016-08-01 2016-07-28 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 15,156 66,478 29.53
2016-05-02 2016-04-30 4 PODD INSULET CORP
Common Stock
F - Taxes -652 21,122 -2.99 33.30 -21,712 703,363
2016-04-05 2016-04-01 4 PODD INSULET CORP
Common Stock
F - Taxes -740 21,774 -3.29 33.52 -24,805 729,864
2016-03-11 2016-03-10 4 PODD INSULET CORP
Stock Option (Right to Buy)
M - Exercise -9,455 0 -100.00
2016-03-11 2016-03-10 4 PODD INSULET CORP
Common Stock
S - Sale -4,699 22,514 -17.27 30.65 -144,024 690,054
2016-03-11 2016-03-10 4 PODD INSULET CORP
Common Stock
M - Exercise 9,455 27,213 53.24 15.14 143,149 412,005
2016-03-11 2016-03-09 4 PODD INSULET CORP
Stock Option (Right to Buy)
M - Exercise -15,545 9,455 -62.18
2016-03-11 2016-03-09 4 PODD INSULET CORP
Common Stock
S - Sale -7,600 17,758 -29.97 31.04 -235,904 551,208
2016-03-11 2016-03-09 4 PODD INSULET CORP
Common Stock
M - Exercise 15,545 25,358 158.41 15.14 235,351 383,920
2016-03-09 2016-03-07 4 PODD INSULET CORP
Common Stock
S - Sale -7,663 9,813 -43.85 31.15 -238,702 305,675
2016-02-25 2016-02-23 4 PODD INSULET CORP
Common Stock
A - Award 6,813 17,476 63.89
2015-07-27 2015-07-23 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 10,379 51,322 25.35
2015-05-04 2015-04-30 4 PODD INSULET CORP
Common Stock
F - Taxes -1,337 10,663 -11.14 29.85 -39,909 318,291
2015-02-11 2015-02-10 4 PODD INSULET CORP
Employee Stock Option (Right to Buy)
A - Award 250,000 250,000
2014-11-24 2014-11-20 4 LPDX LIPOSCIENCE INC
Common Stock
D - Sale to Issuer -10,000 0 -100.00 5.25 -52,500
2014-11-24 2014-11-20 4 LPDX LIPOSCIENCE INC
Common Stock
D - Sale to Issuer -10,077 0 -100.00 5.25 -52,904
2014-07-28 2014-07-24 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 11,804 40,943 40.51
2014-06-13 2014-06-11 4 LPDX LIPOSCIENCE INC
Common Stock
A - Award 8,955 10,077 798.13
2014-06-13 2014-06-02 4 PODD INSULET CORP
Stock Option (Right to Buy)
A - Award 4,000 4,000
2014-06-13 2014-06-02 4 PODD INSULET CORP
Common Stock
A - Award 4,000 12,000 50.00
2013-12-06 2013-12-04 4 LPDX LIPOSCIENCE INC
Common Stock
P - Purchase 10,000 10,000 4.17 41,715 41,715
2013-07-29 2013-07-25 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 14,897 79,139 23.19
2013-06-14 2013-06-12 4 LPDX LIPOSCIENCE INC
Stock option (right to buy)
A - Award 6,736 6,736
2013-06-14 2013-06-12 4 LPDX LIPOSCIENCE INC
Common Stock
A - Award 1,122 1,122
2013-06-05 2013-06-03 4 PODD INSULET CORP
Stock Option (Right to Buy)
A - Award 4,000 4,000
2013-06-05 2013-06-03 4 PODD INSULET CORP
Common Stock
A - Award 4,000 8,000 100.00
2012-07-30 2012-07-26 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 3,340 3,340
2012-07-30 2012-07-26 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
A - Award 4,608 4,608
2012-07-30 2012-07-26 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 4,420 64,242 7.39
2012-06-05 2012-06-01 4 PODD INSULET CORP
Stock Option (Right to Buy)
A - Award 4,000 4,000
2012-06-05 2012-06-01 4 PODD INSULET CORP
Common Stock
A - Award 4,000 4,000
2011-10-25 3 PODD INSULET CORP
No Securities Are Beneficially Owned
0
2008-01-16 2007-10-22 4/A HOLX HOLOGIC INC
Nonqualified Stock Option
A - Award 47,249 47,249
2008-01-16 2007-10-22 4/A HOLX HOLOGIC INC
Incentive Stock Option
A - Award 2,728 2,728
2008-01-16 2007-10-22 4/A HOLX HOLOGIC INC
Nonqualified Stock Option
A - Award 83,793 83,793
2008-01-16 2007-10-22 4/A HOLX HOLOGIC INC
Incentive Stock Option
A - Award 2,708 2,708
2008-01-16 2007-10-22 4/A HOLX HOLOGIC INC
Nonqualified Stock Option
A - Award 54,505 54,505
2008-01-16 2007-10-22 4/A HOLX HOLOGIC INC
Incentive Stock Option
A - Award 3,162 3,162
2008-01-16 2007-10-22 4/A HOLX HOLOGIC INC
Nonqualified Stock Option
A - Award 61,658 61,658
2008-01-16 2007-10-22 4/A HOLX HOLOGIC INC
Incentive Stock Option
A - Award 12,156 12,156
2008-01-16 2007-10-22 4/A HOLX HOLOGIC INC
Common Stock
A - Award 6,334 6,334
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)